Reynders McVeigh Capital Management LLC Has $1.50 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Reynders McVeigh Capital Management LLC trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,868 shares of the medical equipment provider’s stock after selling 104 shares during the period. Reynders McVeigh Capital Management LLC’s holdings in Intuitive Surgical were worth $1,497,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. Norges Bank acquired a new position in Intuitive Surgical during the 4th quarter worth $2,401,493,000. Proficio Capital Partners LLC raised its position in shares of Intuitive Surgical by 89,098.8% during the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after acquiring an additional 948,902 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at $313,769,000. Wilmington Savings Fund Society FSB boosted its holdings in Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after acquiring an additional 552,058 shares during the last quarter. Finally, Vanguard Group Inc. increased its position in Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock worth $16,813,478,000 after purchasing an additional 360,591 shares during the period. 83.64% of the stock is owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 over the last quarter. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of research reports. JPMorgan Chase & Co. upped their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Robert W. Baird reduced their price objective on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 18th. Truist Financial dropped their target price on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a research report on Monday, March 17th. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. Finally, Royal Bank of Canada upped their price objective on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $493.60 on Friday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company’s 50 day moving average price is $532.72 and its two-hundred day moving average price is $532.36. The company has a market capitalization of $175.81 billion, a P/E ratio of 77.00, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.